Rockland Immunochemicals is a life science company that has supported research and development since 1962. Specializing in antibodies and antibody-based tools, it provides products, scientific expertise, and services for basic research, assay development, and emerging therapeutic applications. Its offerings include primary and secondary antibodies, recombinant antibodies, blood products, proteins and peptides, reagents, cell lines and lysates, kits, and specialized TrueBlot and ModDetect products. ModDetect panels are designed to detect nucleic acid modifications independently of sequence, format, or location.

Rockland also supports custom research needs through antibody production, recombinant antibody development, antibody modification, protein and antibody characterization, and assay development. Additional services include cell culture, cell banking and storage, virus particle manufacturing, protein expression and purification, and analytical tools for RNA therapeutics, impurity detection, and gene therapy. The company states that it conducts custom antibody production processes in its own facilities, from initial injection through validation and shipment. Rockland serves research areas including ag biology, biopharma, diagnostics, and emerging therapeutics, and offers protocols, technical tips, white papers, articles, videos, and other scientific resources.